• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

BOKU Shogen  朴 将源

ORCIDConnect your ORCID iD *help
… Alternative Names

朴 将源  ボク ショウゲン

Less
Researcher Number 30755616
Other IDs
Affiliation (Current) 2025: 関西医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help 2023: 関西医科大学, 医学部, 講師
2020 – 2021: 関西医科大学, 医学部, 助教
Review Section/Research Field
Principal Investigator
0908:Society medicine, nursing, and related fields
Except Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related
Keywords
Principal Investigator
大腸癌 / PIK3CA / 低酸素 / グルタミン代謝 / リボソーム / PIK3CA大腸癌 / 大腸がん / PIK3CA遺伝子 / グルタミン / アスピリン … More
Except Principal Investigator
… More レクチン / 糖鎖修飾 / キャピラリー電気泳動 / 血中循環腫瘍細胞 Less
  • Research Projects

    (2 results)
  • Research Products

    (5 results)
  • Co-Researchers

    (1 People)
  •  キャピラリー電気泳動を用いた新規血中循環腫瘍細胞検出技術の開発

    • Principal Investigator
      山本 哲志
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Kindai University
  •  Effect of glutamine metabolism on the anti-tumor effects of aspirinPrincipal Investigator

    • Principal Investigator
      BOKU Shogen
    • Project Period (FY)
      2020 – 2021
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Review Section
      0908:Society medicine, nursing, and related fields
    • Research Institution
      Kansai Medical University

All 2022 2020

All Journal Article Presentation

  • [Journal Article] A chemoproteoinformatics approach demonstrates that aspirin increases sensitivity to MEK inhibition by directly binding to RPS52022

    • Author(s)
      Motoki Watanabe and Shogen Boku
    • Journal Title

      PNAS nexus

      Volume: -

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K23179
  • [Journal Article] Deactivation of Glutaminolysis Sensitizes PIK3CA-Mutated Colorectal Cancer Cells to Aspirin-Induced Growth Inhibition.2020

    • Author(s)
      Boku S, Watanabe M, Sukeno M, Yaoi T, Hirota K, Iizuka-Ohashi M, Itoh K, Sakai T.
    • Journal Title

      Cancers (Basel).

      Volume: 12 Issue: 5 Pages: 1097-1097

    • DOI

      10.3390/cancers12051097

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K23179, KAKENHI-ORGANIZER-17H06391, KAKENHI-PLANNED-17H06398, KAKENHI-PROJECT-19H01079, KAKENHI-PROJECT-18K08874, KAKENHI-PROJECT-18K19693
  • [Presentation] PIK3CA変異大腸癌細胞においてグルタミン代謝阻害がアスピリンに対する感受性を促進する2022

    • Author(s)
      朴将源
    • Organizer
      日本癌学会総会
    • Data Source
      KAKENHI-PROJECT-20K23179
  • [Presentation] Combinatorial treatments of aspirin with glutaminolysis-targeting agents against PIK3CA-mutated colorectal cancer cells2020

    • Author(s)
      Shogen Boku
    • Organizer
      JSMO2021
    • Data Source
      KAKENHI-PROJECT-20K23179
  • [Presentation] Combinatorial treatments of aspirin with glutaminolysis-targeting agents against PIK3CA-mutated colorectal cancer cells2020

    • Author(s)
      Shogen Boku
    • Organizer
      7大学連携個別化がん医療実践者養成プラン 第4回国際がん研究シンポジウム
    • Data Source
      KAKENHI-PROJECT-20K23179
  • 1.  山本 哲志 (20453920)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi